Untitled Design 2025 07 15t144854.397Image Credit Source: Getty Images
GLP-1 and Alzheimrs: GLP-1 medicines are no longer limited to diabetes and obesity. New research suggests that it can also be able to improve brain health, especially in serious diseases like Alzheimer’s. Although it is currently in research, but expectations are big. If you are taking or want to take GLP-1 medicine, then consult your diabetologist or neurologist. In future, these medicines can become a new way to treat both body and brain.
GLP-1 drugs (eg ozempic, wegovy and mounjaro) have emerged as a booster treatment for diabetes and weight loss in recent years. But now scientists see another big possibility in these drugs, that is to treat brain diseases like Alzheimer’s. Recent research has revealed that GLP-1 receptor agonists are not only limited to blood sugar control or weight loss, but they can also have a positive effect on the brain. Let us know what it says, this new discovery and what effect it can have in future.
What are GLP-1 medicines?
GLUCAGON-Like Peptide-1 is a hormone that works to increase insulin secretion in the body, control appetite and reduce blood sugar. GLP-1 drugs made on this principle were earlier used to treat type-2 diabetes, but later they also started to decrease quickly, which also made them popular in the treatment of obesity.
Now how to affect Alzheimer’s?
Studies published in many other journals including Jama Journal and National Institute of Health have shown that GLP-1 drugs can reduce brain inflammation (inflammation) and protect the neuron from damage. In the experiments conducted on mice, it was found that those who had symptoms like Alzheimer’s, GLP-1 drug improved their brain function. This indicated that these drugs can reduce the amyloid plaques and tau proteins formed in the brain – which are considered to be the identity of Alzheimer’s.
In which stage is the research currently?
Many large international clinical trials are going on, where GLP-1 drugs are being given to Alzheimer’s patients. Initial results are encouraging, but research is still at the initial level. Scientists believe that if the results are firm, then it can be a revolutionary change for a disease considered incurable like Alzheimer’s.
Will diabetes and obesity patients also benefit from brain health?
Yes, research shows that patients who are already taking GLP-1 medicines have also shown improvement in brain health. That is, these medicines can have a positive effect on the brain along with controlling diabetes and obesity.
Focus
-GLP-1 medicines should not be taken without doctor’s advice.
– For the treatment of Alzheimer’s, these drugs have not yet received approved as standard therapy.
– You have to wait until the research is completed and the results are firm.